ArticleReviews in cardiovascular medicine2022

Effects of Sodium-Glucose Cotransporter-2 Inhibitors and Thiazolidinedione on New-Onset Atrial Fibrillation Risk to Patients with Type 2 Diabetes.

Haegeun Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.